Skip to main content
Premium Trial:

Request an Annual Quote

US DoD Awards Invitrogen Subsidiary $970K to Develop Protein Arrays for Biothreat Agents

NEW YORK, Jan. 10 (GenomeWeb News) - Invitrogen said today that the US Department of Defense has awarded its Federal Systems subsidiary $970,000 to develop protein microarrays for biothreat agents.

 

The work is designed to support the US Army Medical Research and Material Command, Invitrogen said. The research will be conducted under the direction of James Meegan, senior director of research and development at Invitrogen; and Robert Ulrich of the US Army Medical Research Institute of Infectious Diseases.

 

Invitrogen's ProtoArray protein microarrays consist of complete sets of pure, functional proteins from specific organisms spotted onto glass slides in a high density configuration. Invitrogen developed them in 2001 as a means to enhance the detection and analysis of biomolecular interactions. They are sold using protein sets derived from both the yeast and human genomes.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.